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Androgen Receptor Co-Activator Hic-5/ARA55 as a
Molecular Regulator of Androgen Sensitivity in
Dermal Papilla Cells of Human Hair Follicles
Shigeki Inui1, Yoko Fukuzato1, Takeshi Nakajima1, Sotaro Kurata1 and Satoshi Itami1
Androgen site-specifically affects human hair growth after puberty through androgen receptors in the dermal
papilla, which transactivate target genes acting in conjunction with co-activators. To examine the regulation of
androgen sensitivity in hair follicles, we focused on androgen receptor co-activator Hic-5/ARA55. Its interaction
with transfected androgen receptor in beard dermal papilla cells was confirmed with mammalian two-hybrid
assays. The semiquantitative reverse transcriptase-polymerase chain reaction showed that Hic-5/ARA55 mRNA
expression was high in dermal papilla cells from the beard and bald frontal scalp but low in cells from the
occipital scalp. To determine whether Hic-5/ARA55 mRNA level correlates with its endogenous activity, we
studied the effect of dominant negative Hic-5/ARA55 on transfected androgen receptor transactivation induced
by R1881 using mouse mammary tumor virus-luciferase assays. We found that it suppressed the transactivation
by 64.5 and 71.4% in dermal papilla cells from the beard and bald frontal scalp, respectively, whereas it showed
no significant effect in cells from the occipital scalp. Our findings suggest that Hic-5/ARA55 is a molecular
regulator for androgen sensitivity in human hair follicles.
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INTRODUCTION
Androgen stimulates human hair growth in some sites such as
the beard, auxillary, and pubic areas, but suppresses the
growth of frontal scalp hair in genetically disposed indivi-
duals (Randall et al., 2000). Hair follicles in the occipital
scalp, on the other hand, are insensitive to androgen. The
expression levels of type II 5a-reductase and androgen
receptors in dermal papilla cells, mesenchymal cells of hair
follicles, reportedly correlate well with androgen sensitivity
of the hair follicles (Randall et al., 1992; Thornton et al.,
1993; Itami et al., 1995a; Hamada et al., 1996; Hibberts
et al., 1998). These findings suggest that the primary target
cells in human hair follicles that respond to the action of
androgen are dermal papilla cells, which mediate the signals
to follicular epithelial cells in a paracrine fashion. We
identified previously transforming growth factor-b1 (TGF-b1)
as one of the key mediators in the pathogenesis of
androgenetic alopecia (AGA) (Inui et al., 2002). In addition,
it has been found that androgen receptors are specifically
expressed in the dermal papilla cells of androgen-dependent
hair (Randall et al., 1992; Itami et al., 1995a; Hibberts et al.,
1998) and that androgen receptors cooperate with co-
activators to transactivate target genes (Heinlein and Chang,
2002). Many androgen receptor co-activators have been
cloned with new techniques to detect protein–protein
interaction. However, the post-receptor regulation of andro-
gen sensitivity by the co-activator for human hair follicles
remains largely unknown although ARA70/ELE1 expression
was reported in the dermal papilla cells of the balding scalp
(Lee et al., 2005). In the study reported here, we focus on
androgen receptor co-activator Hic-5/ARA55, the TGF-b1-
inducible androgen receptor co-activator (Shibanuma et al.,
1994; Fujimoto et al., 1999). Moreover, Hic-5/ARA55 has
been found to determine sensitivity to hormone therapy for
prostate cancer (Fujimoto et al., 2001), suggesting that it may
function as a molecular determinant for androgen sensitivity
in tissue. We therefore investigate whether Hic-5/ARA55 may
also act as a molecular regulator for androgen sensitivity in
the dermal papilla cells of human hair follicles.
RESULTS
Interaction of transfected Hic-5/ARA55 and androgen receptors
in beard dermal papilla cells
We performed a mammalian two-hybrid assay to determine
whether transiently transfected androgen receptors and Hic-
5/ARA55 interact in beard dermal papilla cells. Although the
experiments using control vectors showed little luciferase
activity (Figure 1, lanes 1 and 2), synthetic androgen R1881
showed a 2.81-fold increase in induction of reporter activity
compared to that attained with control ethanol treatment
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(Figure 1, lane 3 vs 4). This demonstrates that transfected
androgen receptors and Hic-5/ARA55 can interact in an
androgen-dependent manner in beard dermal papilla cells.
Expression level of Hic-5/ARA55 mRNA in dermal papilla cells
from various sites
We performed semiquantitative reverse transcriptase-poly-
merase chain reaction to compare the expression level of
Hic-5/ARA55 mRNA at different sites. To obtain an adequate
signal intensity yield within the logarithmic linear amplifica-
tion phase, the suitable number of PCR cycles was
determined to be 29 for Hic-5/ARA55 (Figure 2a). The
subsequent semiquantitative reverse transcriptase-polymer-
ase chain reaction study showed that the level of mRNA
expression was high in dermal papilla cells from the beard
and bald frontal scalp, but very low in those from the
occipital scalp (Figure 2b). This suggests that the level of Hic-
5/ARA55 correlates positively with the sensitivity of dermal
papilla cells to androgen.
Effect of dominant negative Hic-5/ARA55 on transfected
androgen receptor transactivity in dermal papilla cells from
various sites
It was reported recently that Hic-5/ARA55 is characterized by
a dual intracellular distribution in the cytoplasm and nucleus
of cells (Shibanuma et al., 2005). This prompted us to
investigate whether the expression level of Hic-5/ARA55
reflects its endogenous potency of co-activation for trans-
fected androgen receptor. Because one study found that the
C-terminal fragment of Hic-5/ARA55 with a point mutation at
amino acid 413 from Ala to Thr functions as a dominant
negative mutant (Rahman et al., 2003), we performed mouse
mammary tumor virus-luciferase assays to examine the effect
of this dominant negative Hic-5/ARA55 (dHic-5/ARA55) on
R1881-induced transactivation of transfected androgen re-
ceptor. As previous findings indicate that, among prostate cell
lines, PC-3 cells but not DU145 cells express Hic-5/ARA55
mRNA (Fujimoto et al., 1999), these cell lines were utilized
as positive and negative controls, respectively. Co-transfected
dHic-5/ARA55 was found to suppress the transactivation of
transfected androgen receptor in PC-3 cells (Hic-5/ARA55-
positive) but not in DU-145 cells (Hic-5/ARA55-negative;
Fujimoto et al., 1999), thus demonstrating the specificity of
this dominant negative mutant for endogenous Hic-5/ARA55
(Figure 3, lanes 4 and 5). We also found that co-transfected
dHic-5/ARA55 significantly suppressed by 64.5% R1881-
induced transactivation of transfected androgen receptor in
dermal papilla cells from the beard and by 71.4% in those
from the bald frontal scalp (Figure 3, lanes 1 and 2).
However, it did not show any significant effect on the
transactivation in dermal papilla cells from the occipital scalp
(Figure 3, lane 3). These results agreed with those for the
expression level of Hic-5/ARA55 mRNA (Figure 2b), again
suggesting that Hic-5/ARA55 may be a molecular regulator
for tissue sensitivity to androgen.
DISCUSSION
Although many androgen receptor co-activators have been
identified (Heinlein and Chang, 2002), their physiological
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Figure 1. Hormone-dependent interaction of transfected Hic-5/ARA55 and
androgen receptors in beard dermal papilla cells. As indicated, primary lines
(n¼3) of beard dermal papilla cells at passage 6 and 50–70% confluency in a
12-well plate were transiently transfected with 0.3mg of Gal4-hybrid
expression plasmid Gal4-ARA55, Gal4-ARA55 expression plasmid VP16-
androgen receptor, empty Gal4 and VP16 vector as controls, pG5-Luc
reporter plasmid, and 0.1 mg of pRL-CMV as internal control. After
transfection, the cells were cultured in the presence of 1 nM R1881 or ethanol.
The luciferase activity is shown as relative to the activity by the internal
control pRL-CMV. Values represent the mean7SD of three independent
experiments. *Po0.05 lane 3 vs 1, 2, and 4; two-sided Mann–Whitney’s U-
test.
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Figure 2. Expression level of Hic-5/ARA55 mRNA in dermal papilla cells
from various sites. (a) The cDNA obtained from beard dermal papilla cells at
passage 5 was amplified as described in Materials and Methods with an
increasing the number of PCR cycles as indicated on the x axis. The y axis
shows the log of arbitrary units used for the NIH image analysis (Ref.: Mr W
Rasband; NIH, Bethesda, MD). (b) Total RNA was isolated from the primary
cell lines (n¼ 3) of dermal papilla cells at passage 5 from AGA bald frontal
scalp (lanes 1, 2, and 3), beard (lanes 4, 5, and 6), and occipital scalp (lanes 7,
8, and 9) at 50–70% confluency in a 6-cm dish. The extracts were subjected to
semiquantitative reverse transcriptase-polymerase chain reaction for Hic-5/
ARA55 as described in Materials and Methods. The lower panel shows
glyceraldehyde-3-phosphate dehydrogenase (G3PDH) expression.
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and pathological significance is still not fully understood.
Hic-5/ARA55 has been reported to be involved in prostate
cancer development and progression (Mestayer et al., 2003;
Miyoshi et al., 2003). Moreover, expression level of Hic-5/
ARA55 was found to determine the reactivity to hormone
therapy in prostate cancer (Fujimoto et al., 2001). These
findings led us to investigate the possibility that Hic-5/ARA55
may function as a molecular regulator for androgen
sensitivity in human hair follicles. A recent study has
demonstrated that another androgen receptor co-activator
ARA70/ELE1 is more weakly expressed in balding than in
non-balding dermal papilla, an observation which seems to
be paradoxical in terms of regulation of androgen sensitivity
(Lee et al., 2005). In our study, the levels of Hic-5/ARA55
were found to correlate with previously reported levels of the
androgen receptor in dermal papilla cells from various
sites (Randall et al., 1992; Itami et al., 1995a; Hibberts
et al., 1998). These findings taken together suggest
that the sensitivity of hair follicles to androgen is regulated
through pre-receptor 5a-reductase (Itami et al., 1990,
1991), androgen receptors, and post-receptor androgen
co-activators.
Previous studies have measured the binding affinities of
androgen receptors (Randall et al., 1992; Hibberts et al.,
1998) and shown that androgen stimulates responses in
dermal papilla cells (Itami et al., 1995b), when cells from
relatively early passages were used (Thornton et al., 1991;
Hibino and Nishiyama, 2004). However, in this study, we
utilized cells from the fifth or sixth passage because the cells
form earlier passages proved to be intractable to transfection
with vectors (data not shown).
TGF-b1 reportedly induces murine hair catagen (Foitzik
et al., 2000), and we found that androgen-inducible TGF-b1
from dermal papilla cells can suppress hair epithelial cell
growth by interfering with paracrine manner signaling
between dermal papilla cells from AGA and hair follicle
epithelium (Inui et al., 2002). As Hic-5/ARA55 was initially
cloned as a TGF-b1-inducible gene (Shibanuma et al., 1994),
this molecule may accelerate the pathogenic pathway in
AGA by increasing sensitivity to androgen. Because other
potential growth factors, such as TGF-b2 (Soma et al., 2002;
Hibino and Nishiyama, 2004), and as yet unidentified
suppressive factors (Hamada and Randall, 2006) may
mediate androgen-induced hair growth suppression, it should
be of interest to investigate crosstalk between growth factor
and androgen signaling to gain a better understanding of
AGA pathogenesis. According to a recent report, the LIM
protein, Hic-5/ARA55, is a focal adhesion protein shuttling in
and out of the nucleus through the redox-sensitive nuclear
export signal (Shibanuma et al., 2005). This means that Hic-5/
ARA55 may be involved by altering various signaling
pathways in the dermal papilla cells.
An increasing number of therapeutic reagents have
become available for AGA. For instance, finasteride, a type
II 5a-reductase inhibitor, induces hair re-growth in AGA
through suppressing the conversion from testosterone to a
more potent androgen, dihydrotestosterone (Shapiro and
Price, 1998). This suggests that the reduction of androgen
activity at one signaling step can overcome hair growth
suppression in AGA by androgen. Finally, we hypothesize
that the attenuation of androgen action at the co-activation
level may also constitute a therapeutic strategy for AGA. We
believe that our findings may result in a new and powerful
tool for developing drugs to treat AGA by targeting Hic-5/
ARA55.
MATERIALS AND METHODS
Reagents
Methyltrienolone (R1881, a synthetic androgen) was dissolved in
ethanol and added to the culture at the concentration of 1 nM. The
dilution ratio of R1881 and ethanol (control) was 1:1,000 in the
culture.
Isolation and culture of human dermal papilla cells
Dermal papilla cells from various body sites of nine males aged from
16 to 43 years were isolated and cultured as described previously
(Itami et al., 1995a). Dermal papilla cells from AGA were isolated
from frontal scalp skin samples of three males with AGA aged 29, 40,
and 43 years. Those beard were from 37-, 40-, and 43-year-old
males. Dermal papilla cells from occipital scalp were from males
aged 16, 20 and 30 years. In brief, skin specimens were obtained at
plastic surgery, and then dermal papilla cells were isolated from
them and cultured in DMEM (Nissui Pharmaceutical, Tokyo, Japan)
supplemented with 10% fetal calf serum (JRH Biosciences, Lenexa,
KS), penicillin (50 U/ml), streptomycin (50 mg/ml) at 371C under a
humidified atmosphere of 95% O2 and 5% CO2. Cells were
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Figure 3. Effect of co-transfected dominant negative Hic-5/ARA55 on
transfected androgen receptor transactivity in dermal papilla cells. The
primary cell lines (n¼ 3) of dermal papilla cells obtained at passage 6 from
beard (lane 1), AGA bald frontal scalp (lane 2), occipital scalp (lane 3), PC-3
cells (Hic-5/ARA55 positive, lane 4), or DU145 cells (Hic-5/ARA55 negative,
lane 5) at 50–70% confluency in a 12-well plate were transiently transfected
with 0.1mg of pSG5-androgen receptor, 0.3mg of the reporter plasmid, the
mouse mammary tumor virus long-terminal repeat-luciferase reporter
plasmid, and 0.1 mg of pRL-CMV vector as an internal control. In addition,
0.5mg of pSG5-dHic-5/ARA55 vector or its empty vector was co-transfected.
The cells were then treated with 1 nM R1881 or ethanol. The graph shows the
stimulation rate (%) or suppression rate (%) of luciferase activity by pSG5-
dHic-5/ARA55 co-transfection in comparison with the activity of the control
sample treated with 1 nM R1881 and transfected with the empty vector in each
type of cell. Error bars, mean7SD from three independent experiments.
*Po0.05 lane 1, 2, and 4 vs control; two-sided Mann–Whitney’s U-test.
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subcultured after 0.025% trypsin treatment (usually 4 weeks after the
beginning of primary cell cultures). For the experiment, dermal
papilla cells in the fifth or sixth passage of subculture were used. The
Medical Ethical Committee of Osaka University approved all
described studies. The study was conducted according to the
Declaration of Helsinki Principles. The donors of the cells gave
their written informed consent.
Semiquantitative reverse transcriptase-polymerase chain
reaction
Total RNA was isolated from the primary cell lines (n¼ 3) of dermal
papilla cells at passage 5 from bald frontal scalp of AGA, beard, or
occipital scalp at 50–70% confluency in a 6-cm dish by the acid
guanidium thiocyanate–phenol–chloroform method. The recovery
and purity of the RNA was calculated from the optical densities at
260 and 280 nm. Total RNA (1mg) from each sample was reverse
transcribed using 2.5 mmol/l random hexamer, 5 mmol/l MgCl2,
50 mmol/l KCl, 10 mmol/l Tris–HCl, pH 8.3, 1 mmol/l each of deoxy-
nucleotide triphosphate, 1.0 U/ml RNase inhibitor (Takara, Tokyo,
Japan), and 2.5 U/ml M-MLV reverse transcriptase (Gibco-BRL,
Gaitherberg, MD). The mixture was incubated at 251C for
10 minutes, followed by 421C for 45 minutes, 991C for 5 minutes,
then 41C for 5 minutes. The resultant cDNA was amplified using a
thermal cycler (Astec, Fukuoka, Japan) in a final volume of 50 ml
containing 2mmol/l MgCl2, 50 mmol/l KCl, 10 mmol/l Tris–HCl, pH
8.3, 0.025 U/ml recombinant Taq DNA polymerase (Takara, Tokyo,
Japan), and 0.5 mmol/l of each of the forward and reverse primers.
The following sense and antisense primers were used for detecting
Hic-5/ARA55: sense primer, 50-GCACTTCGTTTGCGGAGGC-30;
antisense primer, 50-CCGAAGAGCTTCAGGAAGC-30 (Fujimoto
et al., 1999). This combination of primers amplifies 633 bp of the
C-terminal region of ARA55. After an initial denaturation at 951C for
9 minutes, 27 cycles of amplification (denaturation at 941C for
1 minute, annealing at 631C for 1 minute, and extension at 721C for
1 minute) were followed by a terminal extension at 721C for
1 minute. As described previously (Inui et al., 2002), PCR
amplification was performed for 22 cycles (1 minute at 941C,
45 seconds at 601C, and 45 seconds at 721C) for glyceraldehyde-3-
phosphate dehydrogenase (sense primer, 50-CCCATCACCATCTTC-
CAG-30; antisense primer, 50-CCTGCTTCACCACCTTCT-30) as an
internal control. The number of PCR cycles was chosen within the
logarithmic linear amplification range for each primer by densito-
metric analysis. The products were analyzed by 2% agarose gel
electrophoresis, and their sizes ware compared with 100-bp
molecular weight markers (Gibco-BRL, Rockville, MD).
Mammalian two-hybrid assays
Beard dermal papilla cells at 50–70% confluency in a 12-well plate
were transiently transfected with 0.3 mg of Gal4-hybrid expression
plasmid Gal4-ARA55, VP16-hybrid expression plasmid VP16-
androgen receptor, and pG5-Luc reporter plasmid using the
transfection reagent Fugene-6 (Roche Diagnostics Corp., Indianapo-
lis, IN) as described previously (Inui et al., 2002). After transfection,
the cells were cultured in the presence of 1 nM R1881 dissolved in
ethanol or ethanol (control). The final dilution of ethanol in the
cultures was 1:1,000. Gal4-ARA55 and VP16-androgen receptor
(Miyamoto et al., 2004) were kindly gifted from Dr Chawnshang
Chang at University of Rochester.
Reporter gene assays
Dermal papilla cells at 50–70% confluency in a 12-well plate were
transiently transfected with 0.1 mg of pSG5-androgen receptor, 0.3mg
of the reporter plasmid, the mouse mammary tumor virus long-
terminal repeat-luciferase reporter plasmid (Clontech, Palo Alto,
CA), and 0.1 mg of pRL-CMV vector, the Renilla luciferase control
reporter vector driven by the CMV immediate-early enhancer/
promoter as an internal control. The transfection was performed
using the transfection reagent Fugene-6 (Roche Diagnostics Corp.,
Indianapolis, IN) as described previously (Inui et al., 2002). For the
detection of endogenous Hic-5/ARA55 co-activation, we co-
transfected 0.5 mg of the expression vector for dHic-5/ARA55,
pSG5-dHic-5/ARA55, or its empty vector. At 24 hours after transfec-
tion, we added R1881 or ethanol as a control. The final dilution of
ethanol in the cultures was 1:1,000. At 48 hours after transfection,
the cells were harvested for luciferase assays. Luciferase activities
were measured by the luminometer using the Dual-LuciferaseTM
reporter assay system (Promega, Madison WI). The plasmids pSG5-
androgen receptor and pSG5-dHic-5/ARA55 were kindly gifted from
Dr Chawnshang Chang at University of Rochester.
Statistical analysis
The statistical difference was determined by two-sided Mann–Whit-
ney’s U-test. Difference with Po0.05 was considered significant.
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